Literature DB >> 1919926

Metastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters.

J E Martinez1, B L Travi, A Z Valencia, N G Saravia.   

Abstract

The pattern and kinetics of internal dissemination and frequency of cutaneous metastatic lesions resulting from experimental infection of golden hamsters with Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis were examined. Nineteen strains were evaluated: 16 L. (V.) panamensis isolated from patients and 3 L. (V.) guyanensis, 2 isolated from human cases and 1 WHO reference strain originating from a sandfly vector. Lymphatic dissemination occurred within 3 mo and was observed for 16 of 16 (100%) of L. (V.) panamensis and 3 of 3 (100%) of L. (V.) guyanensis. Parasites were cultured infrequently from liver and spleen: 3 of 125 (2%) L. (V.) panamensis and 1 of 22 (5%) L. (V.) guyanensis. Decreased frequency of isolation from the inoculation site and draining lymph nodes over time was accompanied by increased frequency of isolation from distant lymph nodes. Dilution of triturated tissue samples resulted in an increased efficiency of parasite culture. Both primary lesions and secondary cutaneous metastatic lesions were more severe in hamsters infected with L. (V.) guyanensis than with L. (V.) panamensis. Cutaneous metastatic lesions were produced more frequently by L. (V.) guyanensis, 24 of 46 hamsters (52%), than by L. (V.) panamensis, 28 of 252 hamsters (11%). Individual Leishmania strains displayed distinctive propensities to produce cutaneous metastases, manifested as a reproducible phenotype. Metastatic pathogenicity was independent of the inoculum dose, supporting the dissociation of infectivity and pathogenicity.

Entities:  

Mesh:

Year:  1991        PMID: 1919926

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  13 in total

1.  [Mucocutaneous leishmaniasis and an undesired passenger].

Authors:  Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Med Sci (Paris)       Date:  2011-11-30       Impact factor: 0.818

2.  Congenital transmission of experimental leishmaniasis in a hamster model.

Authors:  Yaneth Osorio; Luz D Rodriguez; Diana L Bonilla; Alex G Peniche; Hector Henao; Omar Saldarriaga; Bruno L Travi
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

3.  Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp.

Authors:  Bruno L Travi; Yaneth Osorio; Peter C Melby; Bysani Chandrasekar; Lourdes Arteaga; Nancy G Saravia
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Muco-cutaneous leishmaniasis in the New World: the ultimate subversion.

Authors:  Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

5.  A Mouse Model of Ulcerative Cutaneous Leishmaniasis by Leishmania (Viannia) panamensis to Investigate Infection, Pathogenesis, Immunity, and Therapeutics.

Authors:  Natalia Muñoz-Durango; Alexander Gómez; Natalia García-Valencia; Miguel Roldán; Marcela Ochoa; David E Bautista-Erazo; José R Ramírez-Pineda
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

6.  Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis.

Authors:  Claudia M Espitia; Weiguo Zhao; Omar Saldarriaga; Yaneth Osorio; Lisa M Harrison; Michael Cappello; Bruno L Travi; Peter C Melby
Journal:  BMC Immunol       Date:  2010-06-22       Impact factor: 3.615

7.  Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.

Authors:  Claudia M Espitia; Omar A Saldarriaga; Bruno L Travi; E Yaneth Osorio; Alvaro Hernandez; Mark Band; Mandakini J Patel; Audrie A Medina; Michael Cappello; Andrew Pekosz; Peter C Melby
Journal:  BMC Immunol       Date:  2014-11-26       Impact factor: 3.615

Review 8.  Leishmania RNA virus: when the host pays the toll.

Authors:  Mary-Anne Hartley; Catherine Ronet; Haroun Zangger; Stephen M Beverley; Nicolas Fasel
Journal:  Front Cell Infect Microbiol       Date:  2012-07-12       Impact factor: 5.293

Review 9.  A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.

Authors:  Emily Rose Mears; Farrokh Modabber; Robert Don; George E Johnson
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03

10.  Identification and Biological Characterization of Leishmania (Viannia) guyanensis Isolated from a Patient with Tegumentary Leishmaniasis in Goiás, a Nonendemic Area for This Species in Brazil.

Authors:  Alause da Silva Pires; Arissa Felipe Borges; Adriano Cappellazzo Coelho; Miriam Leandro Dorta; Ruy de Souza Lino Junior; Ledice Inacia de Araújo Pereira; Sebastião Alves Pinto; Milton Adriano Pelli de Oliveira; Grazzielle Guimarães de Matos; Ises A Abrahamsohn; Silvia Reni B Uliana; Glória Maria Collet de Araújo Lima; Fátima Ribeiro-Dias
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.